omeprazole has been researched along with cysteamine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aihara, H; Arai, I; Hirose-Kijima, H; Isobe, Y; Muramatsu, M; Nagai, H; Otomo, S; Usuki-Ito, C | 1 |
| Niida, H; Nishiwaki, H; Okabe, S; Takeuchi, K | 1 |
| Gönne, S; Kromer, W | 1 |
| Kirkegaard, P; Poulsen, SS; Raaberg, L; Skov Olsen, P; Therkelsen, K | 1 |
| Buljat, G; Gjurasin, M; Grabarević, Z; Hanzevacki, M; Jadrijević, S; Jagić, V; Jelovac, N; Jurina, L; Konjevoda, P; Marović, A; Miklić, P; Mikus, D; Mise, S; Perić, J; Perović, D; Petek, M; Rotkvić, I; Rucman, R; Seiwerth, S; Separović, J; Sikirić, P; Turković, B; Zoricić, I | 1 |
| Impicciatore, M; Letari, O; Makovec, F; Mennuni, L; Revel, L | 1 |
| Cheon, HG; Lee, DH; Lee, SS; Lim, H | 1 |
| Deutsch, R; Dohil, R; Newbury, RO; Schneider, JA; Sellers, ZM | 1 |
| Anic, T; Batelja, L; Bedekovic, V; Boban Blagaic, A; Drvis, P; Gjurasin, M; Kalogjera, L; Kopljar, M; Mise, S; Seiwerth, S; Sikiric, P; Staresinic, M | 1 |
| Arakawa, M; Fukuhara, S; Hibi, T; Hosoda, H; Ishii, H; Kangawa, K; Kitajima, M; Masaoka, T; Minegishi, Y; Suzuki, H | 1 |
| Ahn, BO; Choi, SM; Kim, DH; Kim, JM; Kim, WB; Kwon, JW; Oh, TY | 1 |
| Armas, D; Brannagan, M; Checani, GC; Confer, NF; Holt, RJ; Obaidi, M; Xie, Y | 1 |
1 review(s) available for omeprazole and cysteamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for omeprazole and cysteamine
| Article | Year |
|---|---|
A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis.
Topics: Administration, Oral; Adolescent; Adult; Citrus sinensis; Cysteamine; Cystine Depleting Agents; Cystinosis; Delayed-Action Preparations; Drug Interactions; Europe; Female; Fruit and Vegetable Juices; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Water; Young Adult | 2018 |
12 other study(ies) available for omeprazole and cysteamine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
Topics: Animals; Anti-Ulcer Agents; Cold Temperature; Cysteamine; Duodenal Ulcer; Gastric Acid; Histamine; Histamine H2 Antagonists; Indomethacin; Male; Omeprazole; Piperidines; Pylorus; Pyridines; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Physiological | 1990 |
Different effects of cytoprotective drugs on ethanol- and aspirin-induced gastric mucosal injury in pylorus-ligated rats.
Topics: 16,16-Dimethylprostaglandin E2; 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Aspirin; Benzimidazoles; Cysteamine; Ethanol; Gastric Mucosa; Gastrointestinal Motility; Ligation; Omeprazole; Prostaglandins E, Synthetic; Pylorus; Rats | 1990 |
An acid-independent antiulcer effect of M1 antimuscarinics in the rat.
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Cysteamine; Duodenal Ulcer; Female; Gastric Acid; Omeprazole; Parasympatholytics; Pirenzepine; Rats; Rats, Inbred Strains; Receptors, Muscarinic | 1988 |
Effect of antisecretory agents and vagotomy on healing of "chronic" cysteamine-induced duodenal ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Brunner Glands; Chronic Disease; Cimetidine; Cysteamine; Duodenal Ulcer; Female; Gastric Acid; Intestinal Mucosa; Omeprazole; Rats; Rats, Inbred Strains; Vagotomy | 1986 |
Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studies.
Topics: Animals; Anti-Ulcer Agents; Atropine; Bromocriptine; Cimetidine; Cysteamine; Duodenal Ulcer; Female; Gastrectomy; Omeprazole; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar | 1997 |
Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Topics: Animals; Anti-Anxiety Agents; Anti-Ulcer Agents; Benzodiazepines; Benzodiazepinones; Calcium; Cats; Chronic Disease; Cysteamine; Dose-Response Relationship, Drug; Ethanol; Gastric Acid; Gastric Fistula; Gastric Mucosa; Gastrins; Histamine H2 Antagonists; Indomethacin; Male; Omeprazole; Parietal Cells, Gastric; Pentagastrin; Perfusion; Phenylurea Compounds; Rabbits; Ranitidine; Rats; Receptors, Cholecystokinin; Stomach; Stomach Ulcer | 1999 |
Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Cysteamine; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Gastric Acid; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Indomethacin; Omeprazole; Perfusion; Proton Pump Inhibitors; Pyrroles; Quinolines; Rats; Rats, Sprague-Dawley; Sodium Hydroxide; Stomach; Stomach Ulcer; Time Factors | 2001 |
The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine.
Topics: Anti-Ulcer Agents; Child; Child, Preschool; Cysteamine; Cystinosis; Female; Gastric Acid; Gastrins; Gastrointestinal Diseases; Gastroscopy; Humans; Male; Omeprazole; Stomach | 2003 |
Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy.
Topics: Animals; Anti-Ulcer Agents; Atropine; Cysteamine; Duodenal Ulcer; Female; Gastrectomy; Omeprazole; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar; Submandibular Gland | 2003 |
Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cysteamine; Duodenal Ulcer; Gastric Mucosa; Gene Expression; Ghrelin; Lansoprazole; Male; Omeprazole; Peptide Hormones; Rats; Rats, Wistar; Severity of Illness Index; Somatostatin | 2005 |
Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Artemisia; Central Nervous System Depressants; Cysteamine; Drug Therapy, Combination; Esophagitis, Peptic; Ethanol; Gastric Mucosa; Gastritis; Indomethacin; Male; Omeprazole; Peptic Ulcer; Plant Extracts; Rats; Rats, Sprague-Dawley | 2005 |